What the Evidence Actually Shows About 1,3-Propanediol and Skin

1,3-propanediol has spent the past decade migrating from an industrial solvent into humectant lists on moisturizers, serums, and sunscreens, largely on the strength of a safety record built through conventional irritation and sensitization testing rather than through any single headline trial. The ingredient, produced commercially from fermented corn sugar under trade names like Zemea, behaves chemically like a shorter, less viscous cousin of propylene glycol, and formulators have leaned on it partly to sidestep propylene glycol's reputation for triggering contact dermatitis in a subset of users.

The Cosmetic Ingredient Review (CIR) Expert Panel took up 1,3-propanediol as part of its ongoing review of glycols and polyols used in personal care products, publishing its findings in the International Journal of Toxicology. The panel's task was narrow but practical: pull together the available human repeat insult patch test (HRIPT) data, dermal irritation studies, and any sensitization reports, then decide whether current use concentrations in leave-on and rinse-off products fall within a safe margin.

What the panel found was a material that behaves mildly across the concentration ranges actually used in formulation. HRIPT studies conducted on finished products and on the raw ingredient at concentrations reaching into the double digits did not produce meaningful rates of irritation or sensitization among test panelists. That threshold matters more than it might seem: humectants are often the highest-percentage functional ingredient in a formula after water, so an ingredient that stays quiet at 5% but flares at 20% would still carry real formulation risk for leave-on products layered under other actives.

Concentration is where 1,3-propanediol's story gets more specific than a blanket safety label. In modern formulations it typically appears anywhere from under 1% as a minor humectant and solvent up to around 5-10% when it is doing heavier lifting as a texture modifier or as a carrier for fragrance and preservative systems. At the lower end, its main job is drawing and holding water at the skin surface alongside glycerin. At the higher end, formulators use it to cut the tackiness that glycerin alone can leave behind, since 1,3-propanediol has a lighter, less occlusive skin feel. No data reviewed by CIR pointed to a concentration threshold within typical use ranges where irritation risk rises sharply, which is part of why the ingredient has been treated as broadly interchangeable with propylene glycol in reformulation work aimed at reducing allergen labeling concerns.

That interchangeability claim is also where the evidence gets more conditional than marketing language sometimes suggests. Propylene glycol sensitization, when it happens, is thought to involve mechanisms tied to its specific molecular structure, and the absence of comparable reports for 1,3-propanediol is not the same as a mechanistic guarantee that it cannot happen. The CIR panel's conclusion rested on the data available at the time of review, generated mostly through standard HRIPT protocols on panels of a few hundred people, a design suited to catching common irritant and allergic responses but not built to detect rare sensitization events that might only surface after an ingredient reaches the scale of use propylene glycol has had for decades.

There is also the question of what "skin effects" means beyond irritation and allergy. Comedogenicity data on 1,3-propanediol is thinner in the public record than the patch-test literature, which matters for a humectant increasingly marketed toward acne-prone and combination skin as a propylene-glycol alternative. The ingredient's manufacturer has published its own testing showing low comedogenicity scores, but independent replication in peer-reviewed literature remains limited compared with the volume of irritation and sensitization work available.

For formulators reading the CIR conclusions as a green light, the practical takeaway is narrower than a blanket endorsement: the safety margin holds at concentrations reflecting current cosmetic use, tested through the standard toolkit of dermal irritation and repeat insult patch testing, in populations and product types that mirror how the ingredient is actually sold today. Push the concentration meaningfully higher, change the delivery format, or extend use to a population the original panels did not represent, and the existing safety file simply has less to say.